Effects of Pulmonary Rehabilitation Exercises in Patients With Axial Spondyloarthritis

Condition(s) studied

Investigational drug(s) / intervention(s)

Pulmonary Rehabilitation Program: The pulmonary rehabilitation program was administered for 8 weeks in addition to conventional exercise. Participants performed home-based breathing and range-of-motion exercises twice daily for 10 repetitions. Breathing exercises included pursed-lip breathing, diaphragmatic breathing, lateral abdominal breathing, relaxation and breathing control exercises, and neck and shoulder stretching. Participants also performed supervised cycle ergometer exercise twice weekly for 30 minutes per session, including warm-up and cool-down periods, together with upper-extremity and shoulder-girdle strengthening exercises.

Conventional Exercise Program: Participants performed a home-based conventional exercise program. Exercise instructions were provided through a video recording, and participants attended face-to-face follow-up sessions once weekly.

Study summary

This prospective, randomized, single-blind controlled study evaluates the effects of pulmonary rehabilitation exercises in patients with axial spondyloarthritis. Participants were randomized into two groups. The intervention group received a pulmonary rehabilitation program in addition to conventional exercises, while the control group received conventional exercises alone. The primary outcome was pain intensity assessed using the Visual Analog Scale (VAS). Additional assessments included exercise capacity, pulmonary function, disease activity, quality of life, spinal mobility, and chest expansion. Outcomes were evaluated at baseline, week 8, and week 12.

Eligibility

Primary outcome measure(s)

• Change in Pain Intensity Assessed by Visual Analog Scale (VAS) — Baseline, Week 8, and Week 12
  Pain intensity is assessed using a 0-10 cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Changes from baseline are evaluated at Week 8 and Week 12, with Week 12 defined as the primary endpoint.

Trial sites (1)

More Sisli Hamidiye Etfal Training and Research Hospital trials in Turkey

Other trials for the same condition